Canada has released its first major update to pediatric obesity guidelines in nearly two decades, and the recommendations represent a dramatic departure from past approaches
Semaglutide, the drug in Ozempic, is a long-acting medication thats started at a lower dose to reduce the number and severity of side effects as its built up to a higher maintenance dose
Interventional radiologists, nurses, and patients were blinded to the study design
However, translating these findings into clinical applications presents significant challenges [278]
This includes discovery and pretrial motions regarding general causation evidence about the link between Ozempic and ileus, gastroparesis and other injuries, as well as questions about whether the claims are preempted by federal law and whether plaintiffs will be required to provide specific testing evidence to establish they suffered an injury